These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10234761)

  • 1. [Protracted pneumonia: risk factors and therapeutic policy].
    Dantsig II; Skipskiĭ IM; Smul'skaia GP
    Ter Arkh; 1999; 71(3):32-5. PubMed ID: 10234761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effectiveness of antibiotics in typical and atypical pneumonias depending on combination with glucocorticosteroids].
    Skipskiĭ IM; Dantsig II; Radchenko VG
    Klin Med (Mosk); 2007; 85(10):68-70. PubMed ID: 18154187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbial intestinal biocenosis in lingering and complicated course of community pneumonia].
    Osipov MIu; Bilev AE; Osipov IuA
    Ter Arkh; 2008; 80(2):52-7. PubMed ID: 18372597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
    Hu BJ; Wei L; Zhang XZ; Tang YC; Ni YX; Li YM; Guo JQ; Hu YJ; Zhang KX; Yang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):112-6. PubMed ID: 15854394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors and the molecular cellular mechanisms of a protracted course in pneumonia].
    Dandyshev SIu
    Ter Arkh; 1998; 70(3):41-4. PubMed ID: 9575588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
    Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of likely antibiotherapy in bacterial-like acute pneumopathies in patients hospitalized in Africa].
    Koffi N; Ngom A; Kouassi B; Horo K; Mansaré L; Aka-Danguy E
    Bull Soc Pathol Exot; 2001 Dec; 94(5):397-400. PubMed ID: 11889940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for fungal pneumonia in neonates: analysis of 160 cases].
    Yang YX; Luan B; Qiao JY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):705-7. PubMed ID: 19102834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of emergency department crowding measures on time to antibiotics for patients with community-acquired pneumonia.
    Pines JM; Localio AR; Hollander JE; Baxt WG; Lee H; Phillips C; Metlay JP
    Ann Emerg Med; 2007 Nov; 50(5):510-6. PubMed ID: 17913298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Empirical antibacterial therapy of nonhospital pneumonia (review of foreign literature)].
    Strachunskiĭ LS
    Ter Arkh; 2001; 73(3):68-73. PubMed ID: 11417188
    [No Abstract]   [Full Text] [Related]  

  • 12. Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome.
    Lepur D; Barsić B
    Infection; 2007 Jun; 35(4):225-31. PubMed ID: 17646915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implication of BAL in patients with neutropenia.
    Kuehnhardt D; Hannemann M; Schmidt B; Heider U; Possinger K; Eucker J
    Ann Hematol; 2009 Dec; 88(12):1249-56. PubMed ID: 19415277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy.
    Gacouin A; Le Tulzo Y; Lavoue S; Camus C; Hoff J; Bassen R; Arvieux C; Heurtin C; Thomas R
    Intensive Care Med; 2002 Jun; 28(6):686-91. PubMed ID: 12107671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
    Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
    J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonia.
    Kabra SK; Singhal T; Lodha R
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S19-23. PubMed ID: 11980455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease, temporal and sociodemographic influences on initial treatment of community-acquired pneumonia in Manitoba, Canada.
    Carrie AG; Kozyrskyj AL
    Int J Antimicrob Agents; 2006 Aug; 28(2):95-100. PubMed ID: 16843645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.